表紙:生物学的治療薬の世界市場(2021年~2027年)
市場調査レポート
商品コード
1064878

生物学的治療薬の世界市場(2021年~2027年)

Global Biologic Therapeutics Drugs Market 2021-2027

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 100 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
生物学的治療薬の世界市場(2021年~2027年)
出版日: 2022年02月11日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文 100 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の生物学的治療薬の市場規模は、予測期間中にかなりのCAGRで成長すると予測されています。当市場を牽引する主な要因には、がん、糖尿病、CVDなどの慢性疾患の有病率の上昇などがあります。

当レポートでは生物学的治療薬市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、製品タイプ別、用途別、地域別の市場分析、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向

第3章 市場の決定要因

  • 促進要因
  • 抑制要因
  • 市場機会

第4章 市場細分化

  • 世界の生物学的治療薬市場:製品タイプ別
    • 血液・血液製剤
    • ワクチン
    • ヒト細胞・組織
    • 細胞治療
    • アレルゲン抽出物
    • 遺伝子治療
    • その他
  • 世界の生物学的治療薬市場:用途別
    • 関節リウマチ
    • 貧血
    • がん
    • 糖尿病
    • その他

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他アジア太平洋地域
  • その他の地域

第6章 企業プロファイル

  • Pfizer Inc.
  • AstraZeneca Plc
  • Novartis International AG
  • Merck & Co., Inc.
  • GlaxoSmithKline PlC
図表

LIST OF TABLES

  • 1. GLOBAL BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 2. GLOBAL BLOOD AND BLOOD PRODUCTS FOR BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL VACCINES FOR BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL HUMAN CELLS & TISSUES FOR BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL CELLULAR THERAPIES FOR BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL ALLERGENIC EXTRACTS FOR BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL GENE THERAPIES FOR BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL OTHER TYPE BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 10. GLOBAL BIOLOGIC THERAPEUTICS DRUG FOR RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL BIOLOGIC THERAPEUTICS DRUG FOR ANEMIA MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL BIOLOGIC THERAPEUTICS DRUG FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL BIOLOGIC THERAPEUTICS DRUG FOR DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL BIOLOGIC THERAPEUTICS DRUG FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 16. NORTH AMERICAN BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 17. NORTH AMERICAN BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 18. NORTH AMERICAN BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 19. EUROPEAN BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 20. EUROPEAN BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 21. EUROPEAN BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 22. ASIA-PACIFIC BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 24. ASIA-PACIFIC BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 25. REST OF THE WORLD BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 26. REST OF THE WORLD BIOLOGIC THERAPEUTICS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BIOLOGIC THERAPEUTICS DRUG MARKET SHARE BY PRODUCT TYPE, 2020 VS 2027 (%)
  • 2. GLOBAL BIOLOGIC THERAPEUTICS DRUG MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 3. GLOBAL BIOLOGIC THERAPEUTICS DRUG MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 4. US BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 5. CANADA BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. UK BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. FRANCE BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. GERMANY BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. ITALY BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. SPAIN BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. REST OF EUROPE BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. INDIA BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. CHINA BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. JAPAN BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. REST OF THE WORLD BIOLOGIC THERAPEUTICS DRUG MARKET SIZE, 2020-2027 ($ MILLION)
目次
Product Code: OMR2024374

Global Biologic Therapeutics Drugs Market Size, Share & Trends Analysis Report, By Product (Blood and Blood Products, Vaccines, Human Cells and Tissues, Cellular Therapies, Allergenic Extracts, Gene Therapies, and Others), By Application (Rheumatoid Arthritis, Anemia, Cancer, Diabetes and Others), and Forecast (2021-2027)

The global biologic therapeutics drug market is anticipated to grow at a considerable CAGR during the forecast period. The major factors contributing to the growth of the market include the rising prevalence of chronic disorders, including cancer, diabetes, and CVD. According to the World Health Organization (WHO), in 2020, the new cancer incidences reported was 19.3 million. Breast cancer was the most common cancer type in 2020 with almost 2.3 million cases, followed by lung cancer with 2.2 million cases, colon and rectum cancer with 1.9 million cases, prostate cancer with 1.4 million cases, and stomach cancer with 1.1 million cases.

The global biologic therapeutics drug market is segmented based on type and application. Based on type, the biologic therapeutics drug market is segmented into blood and blood products, vaccines, human cells and tissues, cellular therapies, allergenic extracts, gene therapies, and others. Based on application, the biologic therapeutics drug market is segmented into rheumatoid arthritis, anemia, cancer, diabetes and others.

Geographically, the global biologic therapeutics drug market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global biologic therapeutics drug market include Pfizer Inc., AstraZeneca Plc, Novartis International AG, Merck & Co., Inc, and GlaxoSmithKline Plc.

Market Segmentation

1. Global Biologic therapeutics drug market Research and Analysis by Type

2. Global Biologic therapeutics drug market Research and Analysis by Application

The Report Covers

  • Comprehensive research methodology of the global biologic therapeutics drug market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global biologic therapeutics drug market.
  • Insights about market determinants that are stimulating the global biologic therapeutics drug market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Conclusion

3. Market Determinants

  • 3.1. Motivators
  • 3.2. Restraints
  • 3.3. Opportunities

4. Market Segmentation

  • 4.1. Global Biologic Therapeutics Drug Market by Product Type
    • 4.1.1. Blood and Blood Products
    • 4.1.2. Vaccines
    • 4.1.3. Human Cells & Tissues
    • 4.1.4. Cellular Therapies
    • 4.1.5. Allergenic Extracts
    • 4.1.6. Gene Therapies
    • 4.1.7. Others
  • 4.2. Global Biologic Therapeutics Drug Market by Application
    • 4.2.1. Rheumatoid Arthritis
    • 4.2.2. Anemia
    • 4.2.3. Cancer
    • 4.2.4. Diabetes
    • 4.2.5. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Pfizer Inc.
  • 6.2. AstraZeneca Plc
  • 6.3. Novartis International AG
  • 6.4. Merck & Co., Inc.
  • 6.5. GlaxoSmithKline PlC